Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,319
Closed -$319K 148
2023
Q1
$319K Sell
1,319
-534
-29% -$131K 0.05% 105
2022
Q4
$487K Buy
1,853
+112
+6% +$30K 0.08% 72
2022
Q3
$392K Buy
1,741
+178
+11% +$43.1K 0.07% 71
2022
Q2
$380K Buy
1,563
+125
+9% +$30.6K 0.06% 70
2022
Q1
$348K Buy
1,438
+42
+3% +$9.65K 0.05% 78
2021
Q4
$314K Buy
1,396
+154
+12% +$32.5K 0.04% 82
2021
Q3
$264K Buy
1,242
+32
+3% +$7.37K 0.04% 84
2021
Q2
$295K Buy
1,210
+98
+9% +$24.1K 0.04% 75
2021
Q1
$277K Buy
1,112
+55
+5% +$13.1K 0.04% 83
2020
Q4
$243K Buy
+1,057
New +$244K 0.04% 84

Other funds holding AMGN

LVZ Inc's AMGN Position: Q2 2023 in Review

LVZ Inc sold out of Amgen (AMGN) in Q2 2023, closing a stake of 1,319 shares — an estimated $319K sold.

LVZ Inc first reported a position in AMGN in Q4 2020 and held it in 10 quarters. The position peaked at $487K in Q4 2022. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • LVZ Inc reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • LVZ Inc sold 1,319 Amgen shares in Q2 2023, an estimated $319K.
  • LVZ Inc first reported a position in Amgen in Q4 2020 and held it in 10 quarters.
  • LVZ Inc's Amgen position peaked at $487K in Q4 2022.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on LVZ Inc's 13F filing for Q2 2023, filed 18 Jul 2023.